TheProfitWatch

ORIC - Oric Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
11.52 0.05 (0.43%) 0.0 (-0.04%) 0.04 (0.3%) -0.1 (-0.86%) 0.26 (2.26%) 0.0 (0.0%) -0.01 (-0.09%) 0.42 (3.7%)

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.47
Diluted EPS:
-0.47
Basic P/E:
-24.617
Diluted P/E:
-24.617
RSI(14) 1m:
54.17
VWAP:
11.57
RVol:

Events

Period Kind Movement Occurred At

Related News